| Year | Title | Author(s) |
| 2021 |
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
Nature Communications |
Nagy, Z Seneviratne, JA Kanikevich, M Chang, W Mayoh, C Venkat, P Du, YH Jiang, CZ Salib, A Koach, J Carter, DR Mittra, R Liu, T Parker, MW Cheung, BB Marshall, GM |
| 2021 |
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma
Oncogene |
Cheung, BB Kleynhans, A Mittra, R Kim, PY Holien, JK Nagy, Z Ciampa, OC Seneviratne, JA Mayoh, C Raipuria, M Gadde, S Massudi, H Wong, IPL Tan, O Gong, A Suryano, A Diakiw, SM Liu, B Arndt, GM Liu, T Kumar, N Sangfelt, O Zhu, SZ Norris, MD Haber, M Carter, DR Parker, MW Marshall, GM |
| 2020 |
Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma
International Journal Of Molecular Sciences |
Bell, JL Hagemann, S Holien, JK Liu, T Nagy, Z Schulte, JH Misiak, D Huttelmaier, S |